2025-09-03 |
13D/A
|
VTVT / vTv Therapeutics Inc.
|
|
265,620 |
343,223 |
|
|
|
2025-08-14 |
13G/A
|
LPTX / Leap Therapeutics, Inc.
|
|
2,442,352 |
0 |
|
|
|
2025-08-14 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
824,155 |
0 |
|
|
|
2025-08-14 |
13G/A
|
PVLA / Palvella Therapeutics, Inc.
|
|
679,486 |
339,743 |
|
|
|
2025-05-23 |
13D/A
|
ALMS / Alumis Inc.
|
|
|
4,801,370 |
|
|
|
2025-03-27 |
13D/A
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
2,515,523 |
707,114 |
|
|
|
2025-03-25 |
13D
|
KLRS / Kalaris Therapeutics, Inc.
|
|
|
11,448,081 |
|
|
|
2025-03-17 |
13D/A
|
MLYS / Mineralys Therapeutics, Inc.
|
|
5,092,027 |
5,736,305 |
|
|
|
2025-02-14 |
13G/A
|
IOBT / IO Biotech, Inc.
|
|
3,640,015 |
2,631,578 |
|
|
|
2024-12-20 |
13G
|
PVLA / Palvella Therapeutics, Inc.
|
|
|
679,486 |
|
|
|
2024-11-27 |
13G/A
|
NGNE / Neurogene Inc.
|
|
1,282,563 |
1,717,127 |
|
|
|
2024-11-14 |
13G/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
2,780,261 |
3,281,766 |
|
|
|
2024-11-14 |
13G/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
4,121,689 |
4,415,689 |
|
|
|
2024-11-04 |
13G
|
SEPN / Septerna, Inc.
|
|
|
2,768,520 |
|
|
|
2024-10-11 |
13G
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
824,155 |
|
|
|
2024-10-07 |
13D/A
|
SRRK / Scholar Rock Holding Corporation
|
|
7,878,302 |
6,757,255 |
|
|
|
2024-08-27 |
13D
|
|
|
|
3,266,498 |
|
|
|
2024-04-25 |
13G
|
LPTX / Leap Therapeutics, Inc.
|
|
|
2,442,352 |
|
|
|
2024-03-29 |
13D/A
|
NKTX / Nkarta, Inc.
|
|
2,868,035 |
3,768,035 |
|
|
|
2024-03-25 |
13G/A
|
LENZ / LENZ Therapeutics, Inc.
|
|
8,497,067 |
1,213,865 |
|
|
|
2024-03-05 |
13D
|
VTVT / vTv Therapeutics Inc.
|
|
|
265,620 |
|
|
|
2024-02-14 |
13G/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,260,652 |
0 |
|
|
|
2024-02-14 |
13G
|
NGNE / Neurogene Inc.
|
|
|
1,282,563 |
|
|
|
2024-02-12 |
13D/A
|
MLYS / Mineralys Therapeutics, Inc.
|
|
4,521,805 |
5,092,027 |
|
|
|
2023-12-26 |
13D/A
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
1,605,546 |
2,515,523 |
|
|
|
2023-12-18 |
13G
|
IOBT / IO Biotech, Inc.
|
|
|
3,640,015 |
|
|
|
2023-11-22 |
13D/A
|
KDNY / Chinook Therapeutics Inc
|
|
5,181,557 |
0 |
|
|
|
2023-11-21 |
13G
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
4,121,689 |
|
|
|
2023-10-20 |
13D
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
1,605,546 |
|
|
|
2023-10-18 |
13D/A
|
SRRK / Scholar Rock Holding Corporation
|
|
5,676,076 |
7,878,302 |
|
|
|
2023-08-25 |
13G
|
LYRA / Lyra Therapeutics, Inc.
|
|
|
2,780,261 |
|
|
|
2023-02-24 |
13D
|
MLYS / Mineralys Therapeutics, Inc.
|
|
|
4,521,805 |
|
|
|
2023-02-14 |
13D
|
SRRK / Scholar Rock Holding Corporation
|
|
|
5,676,076 |
|
|
|
2023-02-14 |
13G/A
|
GRPH / Graphite Bio, Inc.
|
|
7,851,933 |
8,497,067 |
|
|
|
2023-02-14 |
13G
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
2,260,652 |
|
|
|
2023-02-14 |
13D/A
|
NKTX / Nkarta, Inc.
|
|
2,034,703 |
2,868,035 |
|
|
|
2022-06-01 |
13D
|
KDNY / Chinook Therapeutics Inc
|
|
|
5,181,557 |
|
|
|
2022-02-14 |
13G/A
|
GRPH / Graphite Bio, Inc.
|
|
7,431,623 |
7,851,933 |
|
|
|
2021-07-09 |
13G
|
GRPH / Graphite Bio, Inc.
|
|
|
7,431,623 |
|
|
|
2020-07-22 |
13D
|
NKTX / Nkarta, Inc.
|
|
|
2,034,703 |
|
|
|
2020-03-06 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
2,161,333 |
|
|
|
2020-03-05 |
13G
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
|
5,938,215 |
|
|
|